Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-29 WEISER MICHAEL Director Grant or award · Stock Option (right to buy) +35,000 35,000
2021-06-29 MCPEAK MERRILL A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2021-06-29 Maynard Ryan D Director Grant or award · Stock Option (right to buy) +35,000 35,000
2021-06-29 Dukes Iain D. Director Grant or award · Stock Option (right to buy) +70,000 70,000
2021-06-29 Countouriotis Athena Director Grant or award · Stock Option (right to buy) +35,000 35,000
2021-06-14 Bellemin Jean-Marc Chief Financial Officer Grant or award · Restricted Stock Units +37,700 37,700
2021-06-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Restricted Stock Units +39,380 39,380
2021-06-14 BILINSKY IGOR Chief Operating Officer Grant or award · Restricted Stock Units +37,700 37,700
2021-06-14 Vogt Frederick G Interim CEO & General Counsel Grant or award · Stock Option (right to buy) +100,000 100,000
2021-06-14 Vogt Frederick G Interim CEO & General Counsel Grant or award · Stock Option (right to buy) +73,900 73,900
2021-03-15 BILINSKY IGOR Chief Operating Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2021-01-04 Swartzburg Michael Vice President, Finance (PAO) Grant or award · Stock Option (right to buy) +45,000 45,000
2021-01-04 Fardis Maria President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2021-01-04 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2021-01-04 Vogt Frederick G General Counsel Grant or award · Stock Option (right to buy) +175,000 175,000
2020-12-14 Bellemin Jean-Marc Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2020-06-08 Dukes Iain D. Director Grant or award · Stock Option (right to buy) +70,000 70,000
2020-06-08 MCPEAK MERRILL A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2020-06-08 WEISER MICHAEL Director Grant or award · Stock Option (right to buy) +35,000 35,000
2020-06-08 Maynard Ryan D Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 22 of 23 · 446 trades